Brazil to buy 20 million doses of Bharat Biotech Covaxin

Published On 2021-02-28 04:45 GMT   |   Update On 2021-02-28 04:45 GMT

Brasilia: Brazil's health ministry on Thursday signed a contract to purchase 20 million doses of Covaxin, the Covid-19 vaccine made by India's Bharat Biotech, for delivery between March and May.The ministry said in a statement that the deal is worth 1.6 billion reais ($290,000), with the first 8 million doses expected to arrive in March.To speed up the buying of vaccines in Brazil and deal...

Login or Register to read the full article

Brasilia: Brazil's health ministry on Thursday signed a contract to purchase 20 million doses of Covaxin, the Covid-19 vaccine made by India's Bharat Biotech, for delivery between March and May.

The ministry said in a statement that the deal is worth 1.6 billion reais ($290,000), with the first 8 million doses expected to arrive in March.
To speed up the buying of vaccines in Brazil and deal with the second-deadliest coronavirus outbreak in the world, the ministry said it published new rules last week dispensing with the bidding process.
Brazil reported 1,541 new Covid-19 deaths on Thursday, the second highest daily death toll since the pandemic began, taking total fatalities to 251,498.
With 65,998 new cases, the South American country has now registered 10,390,461 cases, the world's third worst outbreak behind the United States and India.


Tags:    
Article Source : Reuters

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News